Yuyu Pharma, Inc. (KRX:000220)
South Korea · Delayed Price · Currency is KRW 3,885.00
+45.00 (1.17%)
Last updated: Sep 1, 2026, 1:19 PM KST
Yuyu Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 60,470 | 71,100 | 72,903 | 85,445 | 102,750 | 130,082 | |
Market Cap Growth | -11.91% | -2.47% | -14.68% | -16.84% | -21.01% | 20.23% |
Enterprise Value | 72,048 | 84,952 | 76,861 | 119,950 | 114,352 | 120,293 |
Last Close Price | 3840.00 | 4515.00 | 4391.64 | 5032.11 | 5927.98 | 7320.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.52 | 9.08 | 8.36 | - | - | - |
Forward PE | - | 21.92 | 21.92 | 21.92 | 21.92 | 21.92 |
PS Ratio | 0.42 | 0.51 | 0.55 | 0.62 | 0.74 | 1.13 |
PB Ratio | 0.41 | 0.51 | 0.54 | 0.71 | 0.83 | 1.01 |
P/TBV Ratio | 0.46 | 0.57 | 0.61 | 0.81 | 0.93 | 1.11 |
P/FCF Ratio | 10.04 | 9.32 | 4.09 | - | - | - |
P/OCF Ratio | 2.87 | 4.48 | 2.92 | 203.03 | - | 28.85 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.50 | 0.60 | 0.58 | 0.87 | 0.82 | 1.04 |
EV/EBITDA Ratio | 3.72 | 5.11 | 4.21 | 24.69 | 25.78 | 21.09 |
EV/EBIT Ratio | 5.26 | 7.71 | 6.11 | - | - | 100.23 |
EV/FCF Ratio | 11.96 | 11.14 | 4.31 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.19 | 0.20 | 0.25 | 0.33 | 0.32 | 0.30 |
Debt / EBITDA Ratio | 1.49 | 1.68 | 1.84 | 8.11 | 8.86 | 6.87 |
Debt / FCF Ratio | 4.66 | 3.66 | 1.89 | - | - | - |
Net Debt / Equity Ratio | 0.00 | -0.03 | -0.07 | 0.06 | 0.07 | -0.09 |
Net Debt / EBITDA Ratio | 0.01 | -0.29 | -0.49 | 1.45 | 1.92 | -1.95 |
Net Debt / FCF Ratio | 0.03 | -0.63 | -0.50 | -1.72 | -0.74 | 7.09 |
Asset Turnover | 0.71 | 0.68 | 0.66 | 0.70 | 0.72 | 0.67 |
Inventory Turnover | 2.03 | 2.16 | 1.98 | 2.11 | 2.64 | 2.89 |
Quick Ratio | 0.94 | 0.89 | 0.97 | 1.14 | 0.86 | 2.43 |
Current Ratio | 1.89 | 1.64 | 1.58 | 2.03 | 1.50 | 3.30 |
Return on Equity (ROE) | 8.85% | 6.62% | 8.06% | -4.55% | -3.51% | -0.75% |
Return on Assets (ROA) | 4.02% | 3.32% | 3.88% | -0.24% | -0.19% | 0.43% |
Return on Invested Capital (ROIC) | 8.74% | 8.09% | 9.93% | -0.58% | -0.47% | 1.03% |
Return on Capital Employed (ROCE) | 8.20% | 7.40% | 8.80% | -0.50% | -0.50% | 0.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 20.14% | 11.47% | 11.96% | -8.40% | -5.83% | -1.70% |
FCF Yield | 9.96% | 10.72% | 24.47% | -4.79% | -11.20% | -1.20% |
Payout Ratio | 17.07% | 23.66% | - | - | - | - |
Buyback Yield / Dilution | -10.81% | -18.27% | -4.49% | 1.89% | -3.90% | -32.81% |